Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Strengthening pharmacovigilance systems through Africa-Europe collaboration: Insights from a regulatory roundtable discussion. Local targets link to admitted publications; unresolved targets remain external evidence.
Africa Overview 2022.
External reference
Sub-Saharan Africa.
2025 · External reference
Specific features of medicines safety and pharmacovigilance in Africa.
10.1177/2042098611425695 · 2012 · External reference
The Importance of Pharmacovigilance: Safety Monitoring of Medical Products.
2012 · External reference
Pharmacovigilance in high-income countries: current developments and a review of literature.
10.3390/pharmacy11010010 · 2023 · External reference
Harmonization for better health: Members & Observers.
External reference
The global smart pharmacovigilance strategy.
2025 · External reference
Regulation and Prequalification: Pharmacovigilance.
External reference
Pharmacovigilance in low-and middle-income countries: a review with particular focus on Africa.
10.1111/bcp.15193 · 2023 · External reference
Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences.
10.1186/s12992-018-0431-0 · 2018 · External reference
Pharmacovigilance in resource-limited countries.
10.1586/17512433.2015.1053391 · 2015 · External reference
Pharmacovigilance activities in 55 low-and middle-income countries: a questionnaire-based analysis.
10.2165/11536390-000000000-00000 · 2010 · External reference
The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study.
10.11604/pamj.supp.2020.35.2.23671 · 2020 · External reference
The economic impact of substandard and falsified antimalarial medications in Nigeria.
10.1371/journal.pone.0217910 · 2019 · External reference
Challenges to the availability and affordability of essential medicines in African countries: a scoping review.
10.2147/ceor.s413546 · 2023 · External reference
Nanomedicine and regulatory science: the challenges in Africa.
10.3389/fbiom.2023.1184662 · 2023 · External reference
Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria.
10.1007/s40290-024-00524-z · 2024 · External reference
Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous reports in VigiBase®.
10.1007/s40264-015-0387-4 · 2016 · External reference
VigiBase: Resource Profile Update with a Summary of Global Patterns and Trends in Adverse Event Reports for Medicines and Vaccines: JS Brand et al.
10.1007/s40264-025-01642-6 · 2026 · External reference
Challenges and lessons learned from four years of planning and implementing pharmacovigilance enhancement in sub-Saharan Africa.
10.1186/s12889-022-13867-6 · 2022 · External reference
Drug safety in Africa: a review of systems and resources for pharmacovigilance.
10.1080/14740338.2023.2251375 · 2023 · External reference
Advancing Pharmacovigilance Practice in Africa: Moving from Data Collection to Data-Driven Decision Making-Report from the 4th ISoP Africa Chapter Meeting.
10.1007/s40264-025-01598-7 · 2026 · External reference
Pharmacovigilance in resource-limited countries.
10.1586/17512433.2015.1053391 · 2015 · External reference
Medicines Regulation in Africa: Current State and Opportunities.
10.1007/s40290-017-0210-x · 2017 · External reference
Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa.
10.1111/bcp.15193 · 2023 · External reference
Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe.
10.3389/fphar.2018.00280 · 2018 · External reference
Patient involvement in the development, regulation and safe use of medicines. CIOMS Working Group XI report.
2022 · External reference
A Survey on Factors that Could Affect Adverse Drug Reaction Reporting According to Hospital Pharmacists in Great Britain.
10.2165/00002018-200023020-00006 · 2000 · External reference
Effect of social influences on pharmacists’ intention to report adverse drug events.
10.1331/japha.2012.10198 · 2012 · External reference
Data on Strengthening Pharmacovigilance Systems through Africa–Europe Collaboration: Insights from a Regulatory Roundtable Discussion 1 ed.
10.5281/zenodo.21774603 · 2026 · External reference
